RC278

Not specified on website

Not specifiedPipeline asset

Key Facts

Indication
Not specified on website
Phase
Not specified
Status
Pipeline asset
Company

About RemeGen

A leading Chinese biotech developing and commercializing innovative biologics and ADCs for autoimmune diseases, oncology, and ophthalmology.

View full company profile

Other Not specified on website Drugs

DrugCompanyPhase
RC148RemeGenNot specified